| DA/ZtmKini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
10 |
2.8 |
% |
1.26 |
4.0 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68716 |
839 |
| DA.ACI-(D10Rat2-D10Rat29)/Kini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
10 |
0.0 |
% |
0.0 |
0.0 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68723 |
839 |
| DA.PVG.1AV1-(D4Rat155-D4Rat84) |
maximum body weight loss to initial body weight ratio |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
11 |
9.6 |
% |
1.4 |
4.64 |
body weighing method |
0.0 |
|
|
|
|
|
69795 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
Freund's complete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
16 |
3.2 |
% |
1.8 |
7.2 |
body weighing method |
0.0 |
|
|
|
|
|
69796 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
male |
120.0 days-200.0 days |
9 |
7.5 |
% |
2.1 |
6.3 |
body weighing method |
0.0 |
|
|
|
|
|
69802 |
1162 |
| DA.PVG.1AV1-(D4Rat155-D4Rat84) |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
16 |
8.8 |
% |
2.2 |
8.8 |
body weighing method |
0.0 |
|
|
|
|
|
69805 |
1162 |
| DA.PVG.1AV1-(D4Mgh17-D4Rat56) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
male |
120.0 days-200.0 days |
13 |
6.6 |
% |
1.3 |
4.69 |
body weighing method |
0.0 |
|
|
|
|
|
69803 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
10 |
14.3 |
% |
2.5 |
7.91 |
body weighing method |
0.0 |
|
|
|
|
|
69811 |
1162 |
| F344/NHsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
5.7 |
% |
0.9 |
2.85 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107176 |
3077 |
| SS/HsdMcwiCrl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
8 |
3.6 |
% |
0.8 |
2.26 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107182 |
3077 |
| Crl:SD |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
11 |
3.3 |
% |
0.6 |
1.99 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107186 |
3077 |
| ACI/Eur |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
9 |
3.1 |
% |
0.9 |
2.7 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107171 |
3077 |
| DA.PVG.1AV1-(D4Rat155-D4Rat84) |
maximum body weight loss to initial body weight ratio |
Freund's complete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
14 |
5.9 |
% |
3.7 |
13.84 |
body weighing method |
0.0 |
|
|
|
|
|
69797 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
10 |
22.8 |
% |
1.1 |
3.48 |
body weighing method |
0.0 |
|
|
|
|
|
69809 |
1162 |
| FHH/EurMcwiCrl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
6.4 |
% |
0.5 |
1.58 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107187 |
3077 |
| MWF/Hsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
5.1 |
% |
0.8 |
2.53 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107188 |
3077 |
| SR/Hsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
2.2 |
% |
0.7 |
2.21 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107181 |
3077 |
| DA.ACI-(D10Rat2-D10Rat29)/Kini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
7 |
0.0 |
% |
0.0 |
0.0 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68728 |
839 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
12 |
13.4 |
% |
1.4 |
4.85 |
body weighing method |
0.0 |
|
|
|
|
|
69798 |
1162 |
| DA.PVG.1AV1-(D4Rat155-Spr) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
14 |
12.5 |
% |
0.9 |
3.37 |
body weighing method |
0.0 |
|
|
|
|
|
69800 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
9 |
12.8 |
% |
0.9 |
2.7 |
body weighing method |
0.0 |
|
|
|
|
|
69807 |
1162 |
| DA/ZtmKini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
12 |
1.0 |
% |
0.78 |
2.7 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68712 |
839 |
| DA.ACI-(D10Rat2-D10Rat29)/Kini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
10 |
1.2 |
% |
1.14 |
3.6 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68720 |
839 |
| DA.ACI-(D10Rat2-D10Rat29)/Kini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
8 |
0.0 |
% |
0.0 |
0.0 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68725 |
839 |
| DA.PVG.1AV1-(D4Rat155-D4Rat84) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
14 |
2.8 |
% |
1.0 |
3.74 |
body weighing method |
0.0 |
|
|
|
|
|
69799 |
1162 |
| DA.PVG.1AV1-(D4Mgh17-D4Rat56) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
11 |
0.7 |
% |
1.6 |
5.31 |
body weighing method |
0.0 |
|
|
|
|
|
69801 |
1162 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
17 |
14.1 |
% |
1.6 |
6.6 |
body weighing method |
0.0 |
|
|
|
|
|
69804 |
1162 |
| COP/OlaHsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
3.9 |
% |
1.0 |
3.16 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107173 |
3077 |
| NBL/CrCrl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
2.7 |
% |
0.1 |
0.32 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107190 |
3077 |
| DA/ZtmKini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
11 |
14.4 |
% |
2.47 |
8.2 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
CMO:0001400 |
68134 |
839 |
| DA/ZtmKini |
maximum body weight loss to initial body weight ratio |
myelin oligodendrocyte glycoprotein (20 ug) |
Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. |
body mass |
male |
103.0 days-131.0 days |
10 |
3.5 |
% |
1.49 |
4.7 |
body weighing method |
0.0 |
intradermal injection |
40 |
days |
from before p.i. |
|
68708 |
839 |
| DA/Ztm |
maximum body weight loss to initial body weight ratio |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
15 |
12.8 |
% |
0.6 |
2.32 |
body weighing method |
0.0 |
|
|
|
|
|
69794 |
1162 |
| DA.PVG.1AV1-(D4Rat155-Spr) |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
24 |
10.6 |
% |
1.1 |
5.39 |
body weighing method |
0.0 |
|
|
|
|
|
69806 |
1162 |
| DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
squalene (200 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
10 |
6.6 |
% |
2.5 |
7.91 |
body weighing method |
0.0 |
|
|
|
|
|
69808 |
1162 |
| DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
10 |
14.6 |
% |
1.8 |
5.69 |
body weighing method |
0.0 |
|
|
|
|
|
69810 |
1162 |
| DA.PVG.1AV1-(D4Rat63-D4Rat203) |
maximum body weight loss to initial body weight ratio |
pristane (150 ul) |
Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. |
body mass |
both |
120.0 days-200.0 days |
10 |
12.6 |
% |
2.7 |
8.54 |
body weighing method |
0.0 |
|
|
|
|
|
69812 |
1162 |
| SHR/NHsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
4.5 |
% |
0.8 |
2.53 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107184 |
3077 |
| PVG/OlaHsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
5.9 |
% |
1.0 |
3.16 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107180 |
3077 |
| BN/Crl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
3.6 |
% |
0.7 |
2.21 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107185 |
3077 |
| LEW/SsNHsd |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
9 |
5.0 |
% |
0.7 |
2.1 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107178 |
3077 |
| DA/Bkl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
9 |
4.7 |
% |
1.0 |
3.0 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107183 |
3077 |
| BN/HsdMcwiCrl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
11 |
1.5 |
% |
0.6 |
1.99 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107172 |
3077 |
| BDIX/CrCrl |
maximum body weight loss to initial body weight ratio |
arterial catheter implantation (for 1 days) |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
89.0 days-95.0 days |
10 |
3.1 |
% |
0.6 |
1.9 |
body weighing method |
0.0 |
arterial catheter implantation |
1 |
days |
|
|
107189 |
3077 |